This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abramson, D. H.
Right arrow Articles by Ranjithan, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abramson, D. H.
Right arrow Articles by Ranjithan, M.
Related Collections
Right arrow Ophthalmology
PEDIATRICS Vol. 112 No. 6 December 2003, pp. 1248-1255

Screening for Retinoblastoma: Presenting Signs as Prognosticators of Patient and Ocular Survival

David H. Abramson, MD, Katherine Beaverson, MS, Poorab Sangani, MD, Robin A. Vora, MD, Thomas C. Lee, MD, Hilary M. Hochberg, MD, James Kirszrot, MD and Murali Ranjithan, MD

From the Robert M. Ellsworth Ophthalmic Oncology Center, Department of Ophthalmology, New York Presbyterian Hospital–Weill Medical College of Cornell University, New York, New York

Objective. To correlate 3 common presenting signs of retinoblastoma with patient and ocular survival and to assess the efficacy of current pediatric screening practices for retinoblastoma.

Methods. A retrospective study was conducted of 1831 retinoblastoma patients from our center (1914–June 2000). Patient survival (excluding deaths from other primary neoplasms) and ocular survival (presenting eyes) rates were calculated and analyzed using the Kaplan-Meier method.

Results. Leukocoria correlated with excellent patient survival (>86%, 5 years) but poor ocular survival in unilateral (4%, 5 years) and bilateral patients (29%, 5 years). A total of 308 (19%) of 1654 patients presented with strabismus: patient survival was excellent (90%, 5 years), and ocular survival was poor (17%, 5 years) yet better than leukocoria. Patients who had a family history of retinoblastoma and were clinically screened for retinal tumors from birth were diagnosed younger (8 months of age) and earlier (Reese Ellsworth group 1 = 26 [58%] of 45) and had better ocular survival than nonscreened patients with a family history. More patients were initially detected by family/friends (1315 [80%] of 1632) than pediatricians (123 [8%] of 1632) or ophthalmologists (156 [10%] of 1632).

Conclusion. Most US children whose retinoblastoma is diagnosed initially present with leukocoria detected by a parent, despite routine pediatric screening for leukocoria via the red reflex test. Initial disease detection at the point of leukocoria or strabismus correlated with high patient survival rates and poor ocular survival rates for the presenting eye. Saving eyes and vision requires disease recognition before leukocoria, as demonstrated by the better ocular salvage rate among patients who had a positive family history and received clinical surveillance via early, routine dilated funduscopic examinations by an ophthalmologist.

Key Words: retinoblastoma • cancer • leukocoria • red reflex • strabismus

Abbreviations: RE, Reese-Ellsworth • AP, all patients • –FH, no family history of retinoblastoma • +FH, family history of retinoblastoma • SFH, screened family history • AAP, American Academy of Pediatrics

Received for publication Sep 19, 2002; Accepted Mar 19, 2003.




This article has been cited by other articles:


Home page
 Pediatr. Rev.Home page
W. G. Wilson and J. R. Serwint
Retinoblastoma
Pediatr. Rev., January 1, 2007; 28(1): 37 - 38.
[Full Text] [PDF]

Home page
 PediatricsHome page
M. Wallach, A. Balmer, F. Munier, S. Houghton, S. Pampallona, N. von der Weid, M. Beck-Popovic, and on behalf of the Swiss Pediatric Oncology Group an
Shorter Time to Diagnosis and Improved Stage at Presentation in Swiss Patients With Retinoblastoma Treated From 1963 to 2004
Pediatrics, November 1, 2006; 118(5): e1493 - e1498.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
B C Figueiredo, R Sandrini, G P Zambetti, R M Pereira, C Cheng, W Liu, L Lacerda, M A Pianovski, E Michalkiewicz, J Jenkins, et al.
Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation
J. Med. Genet., January 1, 2006; 43(1): 91 - 96.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. Chevez-Barrios, M. Chintagumpala, W. Mieler, E. Paysse, M. Boniuk, C. Kozinetz, M. Y. Hurwitz, and R. L. Hurwitz
Response of Retinoblastoma With Vitreous Tumor Seeding to Adenovirus-Mediated Delivery of Thymidine Kinase Followed by Ganciclovir
J. Clin. Oncol., November 1, 2005; 23(31): 7927 - 7935.
[Abstract] [Full Text] [PDF]

Home page
 JWatch GeneralHome page
Detecting Retinoblastoma: We Can Do Better
Journal Watch (General), December 30, 2003; 2003(1230): 3 - 3.
[Full Text]